bimatoprost tiefenbacher silmatilgad, lahus
alfred e. tiefenbacher gmbh & co. kg - bimatoprost - silmatilgad, lahus - 0,3mg 1ml 2.5ml 3tk; 0,3mg 1ml 3ml 1tk; 0,3mg 1ml 3ml 3tk
unilat silmatilgad, lahus
unimed pharma spol. s r.o. - latanoprost - silmatilgad, lahus - 50mcg 1ml 2.5ml 1tk
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
erysin single shot inj.ad us.vet süsteemulsioon
bioveta a.s. - erysipelothrix rhusiopathiae, inaktiveeritud - süsteemulsioon - 100ml 1tk
lecrolyn sine silmatilgad, lahus
santen oy - kromoglütsiinhape - silmatilgad, lahus - 40mg 1ml 10ml 1tk; 40mg 1ml 5ml 1tk
cosopt sine silmatilgad, lahus
santen oy - timolool+dorsolamiid - silmatilgad, lahus - 5mg+20mg 1ml 10ml 1tk; 5mg+20mg 1ml 10ml 3tk; 5mg+20mg 1ml 10ml 2tk
calcigran sine närimistablett
orifarm healthcare a/s - kaltsiumkarbonaat - närimistablett - 1250mg 30tk; 1250mg 120tk; 1250mg 100tk; 1250mg 60tk
broncophen sine siirup
kwizda pharma gmbh - aed-liivateeürt+alteejuur - siirup - 8mg+55,3mg 1ml 120ml 1tk
taptiqom sine silmatilgad, lahus
santen oy - timolool+tafluprost - silmatilgad, lahus - 5mg+15mcg 1ml 7ml 1tk; 5mg+15mcg 1ml 3ml 3tk; 5mg+15mcg 1ml 5ml 1tk